These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 277944)

  • 1. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
    Drachman DB; Angus CW; Adams RN; Kao I
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
    Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
    N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions.
    Stanley EF; Drachman DB
    Science; 1978 Jun; 200(4347):1285-7. PubMed ID: 663610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.
    Kao I; Drachman DB
    Science; 1977 Apr; 196(4289):527-9. PubMed ID: 850793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.
    Bevan S; Kullberg RW; Heinemann SF
    Nature; 1977 May; 267(5608):263-5. PubMed ID: 865619
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis.
    Drachman DB; Adams RN; Josifek LF; Self SG
    N Engl J Med; 1982 Sep; 307(13):769-75. PubMed ID: 7110241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
    Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
    J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.
    Lindstrom J; Einarson B
    Muscle Nerve; 1979; 2(3):173-9. PubMed ID: 503104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of acetylcholine receptor by antibody against the receptor.
    Heinemann S; Bevan S; Kullberg R; Lindstrom J; Rice J
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3090-4. PubMed ID: 268657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
    Merlie JP; Heinemann S; Einarson B; Lindstrom JM
    J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of myasthenic serum globulin with the acetylcholine receptor.
    Almon RR; Appel SH
    Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to acetylcholine receptor increases degradation of junctional and extrajunctional receptors in adult muscle.
    Reiness CG; Weinberg CB; Hall ZW
    Nature; 1978 Jul; 274(5666):68-70. PubMed ID: 661996
    [No Abstract]   [Full Text] [Related]  

  • 15. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R; Lehar M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenic globulin enhances the loss of acetylcholine receptor clusters.
    Bursztajn S; McManaman JL; Elias SB; Appel SH
    Science; 1983 Jan; 219(4581):195-7. PubMed ID: 6849132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
    Fulpius BW; Miskin R; Reich E
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4326-30. PubMed ID: 6933485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis. Identification of skeletal and heart muscle antigens not related to the acetylcholine receptor.
    Mehl VS; Lang RW
    J Neuroimmunol; 1984 Aug; 6(5):347-60. PubMed ID: 6205020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.